The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials - 17/02/21
Doi : 10.1016/j.jinf.2020.09.034
Thibault Sixt a, Florian Moretto a, Hervé Devilliers b, c, Maroua Abdallahoui b, Isabelle Eberl a, Thomas Rogier b, Michel Duong a, Arnaud Salmon-Rousseau a, Sophie Mahy a, Marielle Buisson a, Clementine Esteve a, Pascal Chavanet a, c, François-Xavier Catherine a, Mathieu Blot a, c, Lionel Piroth a, c, ⁎ 
a Infectious Diseases Department, Dijon University Hospital, France
b Internal medicine department, Dijon University Hospital, France
c INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France
⁎Corresponding author: PIROTH Lionel, Dijon University Hospital Infectious Diseases Department, 14 Paul Gaffarel Street, 21000 DijonPIROTH LionelDijon University Hospital Infectious Diseases Department14 Paul Gaffarel StreetDijon21000
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | There is a need for reliable tools to predict the evolution of hospitalized patients suffering from COVID-19. |
• | The likelihood of unfavourable evolution for patients hospitalized for COVID-19 with a National Early Warning Score 2 (NEWS2) below 7 at Day 7 of hospitalization is nearly non-existent. |
• | Such a score could thus be used to allow earlier discharge of the patients and as a judgement criterion in therapeutic trials. |
Keywords : COVID-19, SARS-CoV2, NEWS2, Prediction, Unfavourable event
Plan
© 2020
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 82 - N° 2
P. 282-327 - février 2021 Retour au numéro
Article précédent
- Home-based SARS-CoV-2 lateral flow antigen testing in hospital workers
- Louise O Downs, David W Eyre, Denise O'Donnell, Katie Jeffery
- Sex differences in mortality in the intensive care unit patients with severe COVID-19
- Sergey Moiseev, Michail Brovko, Ekaterina Tao, Nikolay Bulanov, Larisa Akulkina, Victor Fomin
Bienvenue sur EM-consulte, la référence des professionnels de santé.